In August, the Centers for Medicare & Medicaid Services (CMS) issued Transmittal 1528/Change Request 9255, which addresses instances where hospice claims containing certain anti-cancer and anti-emetic drugs have been returned to provider (RTP). Effective January 1, 2016, systems changes will be implemented that will allow all anti-cancer and anti-emetic drugs to process on hospice claims. …
Are you a Member of NAHC?
Become a member or sign in and read full NAHC Report articles at your leisure. Membership is affordable even if you're a small business and it comes with a lot of other benefits.